A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong Kong - Full Text View

Sponsored by:	Chinese University of Hong Kong
Information provided by:	Chinese University of Hong Kong
ClinicalTrials.gov Identifier:	NCT00786890

Purpose

Hypothesis: A high cardiovascular risk is present in subjects with pre-diabetes in Hong Kong Chinese.

The investigators plan to assess Chinese subjects in Hong Kong who have pre-diabetes (impaired fasting glucose, IFG; or impaired glucose tolerance, IGT) based on oral glucose tolerance test (OGTT) on their cardiovascular risk status such as obesity, hypertension and lipid profile.

Condition	Intervention
Prediabetes Cardiovascular Risk Factors	Other: observational, no intervention needed

MedlinePlus related topics: Diabetes

U.S. FDA Resources

Study Type:	Observational
Study Design:	Case-Only, Prospective
Official Title:	A Survey to Evaluate the Cardiovascular Risk Status of Subjects With Pre-Diabetes in Hong Kong: The Joint Asia Diabetes Evaluation (JADE) Program Sub-Study 2 (JADE-HK2)

Further study details as provided by Chinese University of Hong Kong:

Primary Outcome Measures:

Cardiovascular risk factors: anthroprometric parameters, blood pressure and lipid profiles [ Time Frame: instant ] [ Designated as safety issue: No ]

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	3000
Study Start Date:	November 2008
Estimated Study Completion Date:	January 2014
Estimated Primary Completion Date:	November 2009 (Final data collection date for primary outcome measure)

Groups/Cohorts	Assigned Interventions
no treatment observational, no treatment needed	Other: observational, no intervention needed observational, no intervention needed

Eligibility

Ages Eligible for Study:	12 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

Hong Kong Chinese with pre-diabetes

Criteria

Inclusion Criteria:

Hong Kong Chinese with confirmed IFG or IGT by OGTT

Exclusion Criteria:

Confirmed diabetic patients

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00786890

Locations

China
Hong Kong Institute of Diabetes and Obesity
Hong Kong, China, HK

Sponsors and Collaborators

Chinese University of Hong Kong

More Information

Responsible Party:	Chinese University of Hong Kong ( Hong Kong Institute of Diabetes and Obesity )
Study ID Numbers:	ADF-2008-2
Study First Received:	November 5, 2008
Last Updated:	November 5, 2008
ClinicalTrials.gov Identifier:	NCT00786890
Health Authority:	Hong Kong: Joint CUHK-NTEC Clinical Research Ethics Committee

Keywords provided by Chinese University of Hong Kong:

Prediabetes (IFG, IGT)
Hong Kong Chinese
Cardiovascular risk factors

Study placed in the following topic categories:

Metabolic Diseases
Hyperglycemia
Glucose Intolerance
Prediabetic State
Diabetes Mellitus

Endocrine System Diseases
Endocrinopathy
Metabolic disorder
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on January 16, 2009